D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
1751
PUT
DELISTED
Comerica
CMA
| $2.83M | ﹤0.01% |
29,500
-48,100
| -62% | -$4.59M |
|
|
VIVO
1752
DELISTED
Meridian Bioscience Inc
VIVO
| $2.83M | ﹤0.01% |
199,207
+25,574
| +15% | +$378K |
|
1753
Nu Skin
NUS
$250M
| $2.83M | ﹤0.01% |
+38,332
| New | +$2.72M |
|
|
PRFT
1754
DELISTED
Perficient Inc
PRFT
| $2.82M | ﹤0.01% |
123,005
-16,101
| -12% | -$334K |
|
1755
CALL
Cognex
CGNX
$10.2B
| $2.82M | ﹤0.01% |
54,200
| – | – |
|
|
KTWO
1756
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.82M | ﹤0.01% |
148,621
-13,697
| -8% | -$271K |
|
1757
V2X
VVX
$2.73B
| $2.81M | ﹤0.01% |
75,521
+25,330
| +50% | +$820K |
|
1758
Collegium Pharmaceutical
COLL
$1.15B
| $2.81M | ﹤0.01% |
109,972
-117,300
| -52% | -$2.79M |
|
1759
PUT
D.R. Horton
DHI
$41.3B
| $2.81M | ﹤0.01% |
+64,100
| New | +$2.99M |
|
1760
Oceaneering
OII
$5.19B
| $2.81M | ﹤0.01% |
151,341
-15,823
| -9% | -$317K |
|
1761
CALL
Darden Restaurants
DRI
$23.4B
| $2.81M | ﹤0.01% |
32,900
+15,600
| +90% | +$1.48M |
|
1762
Bath & Body Works
BBWI
$4.13B
| $2.8M | ﹤0.01% |
90,765
-250,673
| -73% | -$9.48M |
|
1763
Adient
ADNT
$1.62B
| $2.8M | ﹤0.01% |
46,816
-189,042
| -80% | -$12.6M |
|
1764
PUT
LGI Homes
LGIH
$1.4B
| $2.79M | ﹤0.01% |
39,600
-17,200
| -30% | -$1.16M |
|
1765
Cerus
CERS
$615M
| $2.79M | ﹤0.01% |
509,997
-158,598
| -24% | -$721K |
|
1766
Atkore
ATKR
$2.54B
| $2.79M | ﹤0.01% |
140,680
+18,642
| +15% | +$401K |
|
1767
NMI Holdings
NMIH
$3.27B
| $2.79M | ﹤0.01% |
168,630
-52,485
| -24% | -$977K |
|
1768
CALL
Puma Biotechnology
PBYI
$407M
| $2.79M | ﹤0.01% |
41,000
| – | – |
|
1769
National Health Investors
NHI
$3.84B
| $2.79M | ﹤0.01% |
41,414
+25,479
| +160% | +$1.74M |
|
1770
TG Therapeutics
TGTX
$8.53B
| $2.78M | ﹤0.01% |
195,524
+107,253
| +122% | +$1.37M |
|
1771
PUT
Albemarle
ALB
$13.7B
| $2.77M | ﹤0.01% |
29,900
+9,900
| +50% | +$1.09M |
|
|
1772
Darden Restaurants
DRI
$23.4B
| $2.77M | ﹤0.01% |
32,461
-45,538
| -58% | -$4.31M |
|
1773
SM Energy
SM
$7.26B
| $2.77M | ﹤0.01% |
153,462
-265,998
| -63% | -$5.75M |
|
1774
Digi International
DGII
$2.55B
| $2.77M | ﹤0.01% |
268,531
-9,516
| -3% | -$98.8K |
|
|
CSW
1775
CSW Industrials
CSW
$4.78B
| $2.75M | ﹤0.01% |
61,159
-428
| -0.7% | -$19.9K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.